Glaxo heart drug that failed trial shows potential benefit
WASHINGTON (Reuters) - A new type of heart drug being developed by GlaxoSmithKline, which failed the main goal of a Phase III study of patients with c...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/OMea4KizGjQ/story01.htm
No comments:
Post a Comment